We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORDS:QSEOoredoo Q.P.S.C Analysis

Data as of 2026-03-11 - not real-time

QAR 13.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Ooredoo Q.P.S.C. is trading at 13.00 QAR, just below its 20‑day and 50‑day SMAs of 13.65 and 13.64, but comfortably above the 200‑day SMA of 13.18, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 42 suggests neutral momentum while the MACD histogram remains negative, signaling bearish pressure that could test the near support level of 12.57. Volume is on an increasing trend, providing liquidity for any breakout, and the stock’s beta of 0.06 points to minimal market‑wide volatility despite a 30‑day volatility of 34.6%. Fundamentally, the company boasts a PE of 10.7 versus an industry average of 18.2, a healthy dividend yield of 5.73%, and a DCF‑derived fair value of 18.4 QAR, implying roughly 30% upside. Recent FY2025 results highlighted a record net profit, reinforcing earnings momentum and supporting the dividend payout ratio of 53.7%. Given the blend of modest growth, strong cash generation, and attractive valuation, the stock presents a compelling case for investors with a medium‑to‑long‑term horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support at 12.57
  • Bearish MACD histogram indicating downside pressure
  • Increasing volume providing liquidity for range‑bound trading

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF fair value and peer PE
  • Strong cash position with cash exceeding debt
  • Solid revenue growth and record FY2025 profit

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable high dividend yield with moderate payout ratio
  • Low beta and stable telecom sector fundamentals
  • Strategic geographic diversification across MENA and Asia

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin15.65%
P/E Ratio10.7
ROE13.78%
ROA5.59%
Debt/Equity46.54
P/B Ratio1.4
Op. Cash FlowQAR8.8B
Free Cash FlowQAR3.1B
Industry P/E18.2

Technical Analysis

TrendBullish
RSI42.0
SupportQAR 12.57
ResistanceQAR 14.57
MA 20QAR 13.65
MA 50QAR 13.64
MA 200QAR 13.18
MACDBearish
VolumeIncreasing
Fear & Greed Index76.61

Valuation

Fair ValueQAR 18.40
Target PriceQAR 16.95
Upside/Downside30.38%
GradeUndervalued
TypeBlend
Dividend Yield5.73%

Risk Assessment

Beta0.07
Volatility34.59%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.